Curewiki
Get the case study →

Stop guessing whether your study can enrol. See who already fits.

Patients come to Curewiki through their hospital or patient organisation, self-pre-screen against your protocol in plain language, and raise their hand. You see a consented, eligible funnel before you commit a single site visit.

  • One biotech: a consented, eligible funnel in under 5 months. Zero outreach.
  • Mismatches filter themselves out before your coordinators see them.
  • An early fit signal you can act on before you spend on site activation.

Backed by 20+ patient organisations, hospitals and research bodies across Europe, including Innodia, UZ Gent and CHU Brugmann.

Free case study1 page · 2-min readGDPR-native

How a biotech built a consented funnel in under 5 months, without hunting for patients

The mechanism, the timeline, and what the funnel looked like. Ready to circulate internally.

No spam. No sales call unless you ask. GDPR-ready.

Trusted across Europe's clinical research network

Innodia
UZ Gent
CHU Brugmann
Dedalus
Sciensano
ELPA

GDPR-native · EU AI Act compliant · pre-screening outside Ethics Committee scope by design

80% of clinical trials miss their original enrolment timeline. More than half of terminated trials failed because they could not enrol. A consented funnel, seen early, changes that math.

Patient-initiated by design

Patients reach you already pre-screened.

People come to us through their patient organisation, their hospital, or directly, and register a consented willingness to take part. When your study opens, we surface it to the patients who fit.

Step 01

Patients register willingness

Direct, consented, patient-initiated. No outreach from us.

Step 02

Your study opens

We translate your criteria into plain-language self-pre-screening.

Step 03

Patients self-pre-screen

Obvious mismatches filter themselves out, in plain language.

Step 04

You see the fit signal

A consented, eligible funnel, before you commit a site visit.

The funnel compounds: a patient who pre-screens today can be re-engaged when a fitting study opens next year.

What pre-screening is, and isn't

Built to survive a clinician's scrutiny.

On data

Consent at the source

Every record is zero-party, declared by the patient, revocable at any moment, aligned to GDPR. No scraping. No purchased lists.

On accuracy

Patients answer what they can actually know

Questions that need biomarkers or an activity index stay for the on-site visit. Fewer false positives reach your coordinators.

On scope

A signal, not a diagnosis

Self-pre-screening narrows the funnel and flags fit. Final eligibility always sits with the site, and the patient flow says so.

Enrolment validation

We track pre-screening-to-enrolment per therapeutic area and are honest about where the data is still maturing. Ask for the numbers in your indication.

Compliance-native

The questions legal and procurement will ask. Already answered.

GDPR

Operational

Our technical team is based in Belgium and we operate under GDPR.

Operational
EU AI Act

Compliant

Risk classification mapped, model documentation maintained, human oversight built in.

Compliant
EC position

Outside EC scope

Pre-screening sits outside Ethics Committee scope: patient-initiated, neutral, never study-specific.

Documented
ISO 27001

In progress

Implementation underway. Certification expected this fiscal year.

In progress

Before you ask

The questions clinical teams ask us.

What is patient-initiated pre-screening?
Patient-initiated pre-screening is an approach where patients themselves register a consented willingness to take part in clinical research, then self-pre-screen against a study's criteria in plain language. Unlike traditional recruitment, no one hunts or contacts patients: they raise their hand first, and sponsors see a consented, eligible funnel before committing to site visits.
Is this patient recruitment?
No. Curewiki is patient-initiated discovery. Patients come to us through their patient organisation, hospital, or directly, and register a consented willingness to take part in research. We never hunt, buy lists, or run recruitment on your behalf. When your study opens, we surface it to patients who already raised their hand.
Can patients really self-pre-screen accurately?
Against the right questions, yes. We translate your protocol into plain-language criteria a patient can genuinely answer, and anything that needs clinical data (biomarkers, activity indices) stays with the site. Self-pre-screening is a funnel-narrowing signal, not an eligibility decision. Final eligibility always sits with your site.
Do we need Ethics Committee approval to use it?
Pre-screening sits outside Ethics Committee scope by design: it is patient-initiated, neutral, and never study-specific. Our regulatory position is documented in a one-pager written with our DPO and legal counsel, ready to share with your EC or regulatory team.
Where does the patient data live, and who controls it?
The patient does. Every record is zero-party, declared directly by the patient, with explicit, revocable consent aligned to GDPR. Our technical team is based in Belgium and we operate under GDPR. Sponsor, site and patient see the same record, which simplifies legal and procurement review.
What does it take to get started?
Your protocol criteria and a conversation. We translate the criteria into patient-friendly self-pre-screening; there is no site integration required to begin. Scope and pricing are per study, and we share them in the first conversation, not after a procurement maze.

Next step

Built for your next trial.

One page, two minutes, ready to circulate internally. And pre-screening is the front door: the same consented network supports panels, surveys and real-world insights when you need them.

Prefer to talk it through first? Book a 30-minute intro →

Free case study1 page · 2-min read

How a biotech built a consented funnel in under 5 months, without hunting for patients

No spam. No sales call unless you ask. GDPR-ready.

Backed by 20+ patient organisations, hospitals and research bodies across Europe.